Literature DB >> 15892588

Antidepressants and sleep: a qualitative review of the literature.

Sue Wilson1, Spilios Argyropoulos.   

Abstract

Most antidepressants change sleep; in particular, they alter the physiological patterns of sleep stages recorded overnight with EEG and other physiological measures. These effects are greatest and most consistent on rapid eye movement (REM) sleep, and tend to be in the opposite direction to the sleep abnormalities found in major depression, but are usually of greater degree. Reductions in the amount of REM sleep and increases in REM sleep onset latency are seen after taking antidepressants, both in healthy volunteers and in depressed patients. Antidepressants that increase serotonin function by blocking reuptake or by inhibiting metabolism have the greatest effect on REM sleep. The decrease in amount of REM sleep appears to be greatest early in treatment, and gradually diminishes during long-term treatment, except after monoamine oxidase inhibitors when REM sleep is often absent for many months. Sleep initiation and maintenance are also affected by antidepressants, but the effects are much less consistent between drugs. Some antidepressants such as clomipramine and the selective serotonin receptor inhibitors (SSRIs), particularly fluoxetine, are sleep-disturbing early in treatment and some others such as amitriptyline and the newer serotonin 5-HT2-receptor antagonists are sleep promoting. However, these effects are fairly short-lived and there are very few significant differences between drugs after a few weeks of treatment. In general, the objectively measured sleep of depressed patients improves during 3-4 weeks of effective antidepressant treatment with most agents, as does their subjective impression of their sleep. Sleep improvement earlier in treatment may be an important clinical goal in some patients, perhaps when insomnia is particularly distressing, or to ensure compliance. In these patients, the choice of a safely used and effective antidepressant which improves sleep in short term is indicated. Patients with other sleep disorders such as restless legs syndrome and REM sleep behaviour disorder should be identified before choosing a treatment, as some antidepressants worsen these conditions. Conversely, there is evidence that some antidepressants may be useful in the treatment of sleep disorders such as night terrors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15892588     DOI: 10.2165/00003495-200565070-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  143 in total

1.  Sleep and sleep electroencephalogram in depressed patients treated with phenelzine.

Authors:  H P Landolt; E B Raimo; B J Schnierow; J R Kelsoe; M H Rapaport; J C Gillin
Journal:  Arch Gen Psychiatry       Date:  2001-03

2.  Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.

Authors:  C R Rush; R W Baker; K Wright
Journal:  Psychopharmacology (Berl)       Date:  1999-06       Impact factor: 4.530

3.  Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.

Authors:  D Riemann; U Voderholzer; S Cohrs; A Rodenbeck; G Hajak; E Rüther; M H Wiegand; G Laakmann; T Baghai; W Fischer; M Hoffmann; F Hohagen; G Mayer; M Berger
Journal:  Pharmacopsychiatry       Date:  2002-09       Impact factor: 5.788

4.  The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects.

Authors:  J C Ware; F V Rose; R H McBrayer
Journal:  Sleep       Date:  1994-09       Impact factor: 5.849

5.  Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers.

Authors:  J C Gillin; W Jernajczyk; D C Valladares-Neto; S Golshan; M Lardon; S M Stahl
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

Review 6.  Drug induced nightmares--an etiology based review.

Authors:  J F Pagel; P Helfter
Journal:  Hum Psychopharmacol       Date:  2003-01       Impact factor: 1.672

7.  Subjective and polysomnographic effects of milnacipran on sleep in depressed patients.

Authors:  Patrick Lemoine; Thierry Faivre
Journal:  Hum Psychopharmacol       Date:  2004-07       Impact factor: 1.672

8.  Estimation of the time course of slow-wave sleep over the night in depressed patients: effects of clomipramine and clinical response.

Authors:  C L Ehlers; J W Havstad; D J Kupfer
Journal:  Biol Psychiatry       Date:  1996-02-01       Impact factor: 13.382

9.  Response of obstructive sleep apnea to fluoxetine and protriptyline.

Authors:  D A Hanzel; N G Proia; D W Hudgel
Journal:  Chest       Date:  1991-08       Impact factor: 9.410

10.  Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.

Authors:  E Aguglia; M Casacchia; G B Cassano; C Faravelli; G Ferrari; P Giordano; P Pancheri; L Ravizza; M Trabucchi; F Bolino
Journal:  Int Clin Psychopharmacol       Date:  1993       Impact factor: 1.659

View more
  73 in total

1.  Modeling hot flushes and quality of life in breast cancer survivors.

Authors:  K L Rand; J L Otte; D Flockhart; D Hayes; A M Storniolo; V Stearns; N L Henry; A Nguyen; S Lemler; J Hayden; S Jeter; J S Carpenter
Journal:  Climacteric       Date:  2010-05-07       Impact factor: 3.005

2.  Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment.

Authors:  Szilvia Vas; Zita Kátai; Diána Kostyalik; Dorottya Pap; Eszter Molnár; Péter Petschner; Lajos Kalmár; György Bagdy
Journal:  J Neural Transm (Vienna)       Date:  2012-06-24       Impact factor: 3.575

3.  A Longitudinal Twin and Sibling Study of Associations between Insomnia and Depression Symptoms in Young Adults.

Authors:  Alice M Gregory; Fruhling V Rijsdijk; Thalia C Eley; Daniel J Buysse; Melanie N Schneider; Mike Parsons; Nicola L Barclay
Journal:  Sleep       Date:  2016-11-01       Impact factor: 5.849

4.  Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls.

Authors:  Robin L Carhart-Harris; David J Nutt; Marcus R Munafo; David M Christmas; Sue J Wilson
Journal:  Psychopharmacology (Berl)       Date:  2009-07-08       Impact factor: 4.530

5.  Differential mechanisms underlie the regulation of serotonergic transmission in the dorsal and median raphe nuclei by mirtazapine: a dual probe microdialysis study.

Authors:  Kouji Fukuyama; Shunske Tanahashi; Tatsuya Hamaguchi; Masanori Nakagawa; Takashi Shiroyama; Eishi Motomura; Motohiro Okada
Journal:  Psychopharmacology (Berl)       Date:  2013-05-09       Impact factor: 4.530

Review 6.  Sleep neurobiology from a clinical perspective.

Authors:  Rodrigo A España; Thomas E Scammell
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

Review 7.  Neurochemical mechanisms for memory processing during sleep: basic findings in humans and neuropsychiatric implications.

Authors:  Gordon B Feld; Jan Born
Journal:  Neuropsychopharmacology       Date:  2019-08-23       Impact factor: 7.853

8.  Association Between Nonmedical Use of Prescription Drugs and Sleep Quality in a Large College Student Sample.

Authors:  Yahya A Alamir; Keith J Zullig; Sijin Wen; Hawley Montgomery-Downs; Alfgeir L Kristjansson; Ranjita Misra; Jianjun Zhang
Journal:  Behav Sleep Med       Date:  2017-12-22       Impact factor: 2.964

9.  Do sleep problems mediate the link between adverse childhood experiences and delinquency in preadolescent children in foster care?

Authors:  Erin P Hambrick; Sonia L Rubens; Thomas W Brawner; Heather N Taussig
Journal:  J Child Psychol Psychiatry       Date:  2017-09-01       Impact factor: 8.982

Review 10.  The neurobiological basis of sleep: Insights from Drosophila.

Authors:  Sarah Ly; Allan I Pack; Nirinjini Naidoo
Journal:  Neurosci Biobehav Rev       Date:  2018-01-31       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.